{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:53:01Z","timestamp":1758394381011,"version":"3.40.3"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2309790"],"award-info":[{"award-number":["RF2309790"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/jid.2014.499","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T11:06:46Z","timestamp":1423566406000},"page":"651-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clonal Analysis of B-Cell Response in Pemphigus Course: Toward More Effective Therapies"],"prefix":"10.1016","volume":"135","author":[{"given":"Giovanni","family":"Di Zenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Zambruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.499_bb0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/jid.2011.390","article-title":"Desmoglein as a target in skin disease and beyond","volume":"132","author":"Amagai","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.499_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000131453","article-title":"Pemphigus vulgaris and its active disease mouse model","volume":"10","author":"Amagai","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"10.1038\/jid.2014.499_bb0020","article-title":"An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab","author":"Amber","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2014.499_bb0025","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","volume":"5","author":"Cho","year":"2014","journal-title":"Nat Commun"},{"key":"10.1038\/jid.2014.499_bb0030","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2014.499_bb0035","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.499_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.499_bb0045","article-title":"Persistence of anti-desmoglein 3 IgG+ B-cell clones in pemphigus patients over years","author":"Hammers","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.499_bb0050","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/jid.2013.521","article-title":"Antibody phage display: technique and applications","volume":"134","author":"Hammers","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.499_bb0055","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI68775","article-title":"Specific peripheral B cell tolerance defects in patients with multiple sclerosis","volume":"123","author":"Kinnunen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.499_bb0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","article-title":"Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients","volume":"148","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2014.499_bb0065","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2133.1999.03209.x","article-title":"Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression","volume":"141","author":"Miyagawa","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.499_bb0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.499_bb0075","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1172\/JCI44425","article-title":"Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity","volume":"120","author":"Yamagami","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.499_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clim.2006.03.006","article-title":"Pathogenic human monoclonal antibody against desmoglein 3","volume":"120","author":"Yeh","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1038\/jid.2014.499_bb0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:52:24Z","timestamp":1743976344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15371669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0022202X15371669"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.499","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal Analysis of B-Cell Response in Pemphigus Course: Toward More Effective Therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}